Yaldizli Ö - Search Results

1

Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis.

Müller J, Roos I, Kalincik T, Lorscheider J, Galli E, Benkert P, Schädelin S, Sharmin S, Einsiedler M, Hänni P, Schmid J, Kuhle J, Derfuss T, Granziera C, Ziemssen T, Siepmann T, Yaldizli Ö. Müller J, et al. Among authors: yaldizli o. Brain Behav. 2024 May;14(5):e3498. doi: 10.1002/brb3.3498. Brain Behav. 2024. PMID: 38688877 Free PMC article.

2

Copper deficiency myelopathy induced by repetitive parenteral zinc supplementation during chronic hemodialysis.

Yaldizli O, Johansson U, Gizewski ER, Maschke M. Yaldizli O, et al. J Neurol. 2006 Nov;253(11):1507-9. doi: 10.1007/s00415-006-0259-z. Epub 2006 Sep 13. J Neurol. 2006. PMID: 16972121 No abstract available.

3

Transcranial sonography of the third ventricle and cognitive dysfunction in HIV patients.

Yaldizli O, Kastrup O, Obermann M, Esser S, Wilhelm H, Ley C, Forsting M, Maschke M. Yaldizli O, et al. J Neurol. 2006 Sep;253(9):1185-8. doi: 10.1007/s00415-006-0191-2. Epub 2006 Sep 21. J Neurol. 2006. PMID: 16990993

4

Carotid intima-media thickness in HIV-infected individuals: relationship of premature atherosclerosis to neuropsychological deficits?

Yaldizli O, Kastrup O, Obermann M, Esser S, Wilhelm H, Ley C, Diener HC, Maschke M. Yaldizli O, et al. Eur Neurol. 2006;55(3):166-71. doi: 10.1159/000093576. Epub 2006 May 29. Eur Neurol. 2006. PMID: 16733357

5

Tobacco smoking and depression--results from the WHO/ISBRA study.

Wiesbeck GA, Kuhl HC, Yaldizli O, Wurst FM; WHO/ISBRA Study Group on Biological State and Trait Markers of Alcohol Use and Dependence. Wiesbeck GA, et al. Among authors: yaldizli o. Neuropsychobiology. 2008;57(1-2):26-31. doi: 10.1159/000123119. Epub 2008 Apr 18. Neuropsychobiology. 2008. PMID: 18424908

6

Risk factors for suicide attempts in patients with alcohol dependence or abuse and a history of depressive symptoms: a subgroup analysis from the WHO/ISBRA study.

Yaldizli O, Kuhl HC, Graf M, Wiesbeck GA, Wurst FM. Yaldizli O, et al. Drug Alcohol Rev. 2010 Jan;29(1):64-74. doi: 10.1111/j.1465-3362.2009.00089.x. Drug Alcohol Rev. 2010. PMID: 20078685

7

Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.

Gensicke H, Leppert D, Yaldizli Ö, Lindberg RL, Mehling M, Kappos L, Kuhle J. Gensicke H, et al. Among authors: yaldizli o. CNS Drugs. 2012 Jan 1;26(1):11-37. doi: 10.2165/11596920-000000000-00000. CNS Drugs. 2012. PMID: 22171583 Review.

8

Screening for balance disorders in mildly affected multiple sclerosis patients.

Fanchamps MH, Gensicke H, Kuhle J, Kappos L, Allum JH, Yaldizli O. Fanchamps MH, et al. Among authors: yaldizli o. J Neurol. 2012 Jul;259(7):1413-9. doi: 10.1007/s00415-011-6366-5. Epub 2011 Dec 21. J Neurol. 2012. PMID: 22186852

9

Balance control in multiple sclerosis: correlations of trunk sway during stance and gait tests with disease severity.

Corporaal SH, Gensicke H, Kuhle J, Kappos L, Allum JH, Yaldizli Ö. Corporaal SH, et al. Among authors: yaldizli o. Gait Posture. 2013 Jan;37(1):55-60. doi: 10.1016/j.gaitpost.2012.05.025. Epub 2012 Aug 5. Gait Posture. 2013. PMID: 22874664

10

Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.

Papadopoulou A, Menegola M, Kuhle J, Ramagopalan SV, D'Souza M, Sprenger T, Radue EW, Kappos L, Yaldizli Ö. Papadopoulou A, et al. Among authors: yaldizli o. Mult Scler. 2014 Mar;20(3):322-30. doi: 10.1177/1352458513495583. Epub 2013 Jul 11. Mult Scler. 2014. PMID: 23846352 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters